Nuvation Bio is trading at $5.28, down 5.13%, with no clear company-specific announcement explaining the October 2 decline.

  • The latest item on the company news feed was dated September 2.
  • Broad markets were higher; a separate market snapshot reported Nuvation Bio down 3.42% at 10:08 a.m., so the decline did not appear to follow the market’s overall direction.